Klaus Kutz
Chief Tech/Sci/R&D Officer bei PROPANC BIOPHARMA, INC.
Profil
Klaus Kutz is associated with Propanc Biopharma, Inc., the University of Bonn, and RESprotect GmbH.
He holds the position of Chief Medical Officer at Propanc Biopharma, Inc. and RESprotect GmbH, and is a Professor at the University of Bonn.
Aktive Positionen von Klaus Kutz
| Unternehmen | Position | Beginn |
|---|---|---|
| PROPANC BIOPHARMA, INC. | Chief Tech/Sci/R&D Officer | - |
RESprotect GmbH
 RESprotect GmbH Pharmaceuticals: OtherHealth Technology RESprotect GmbH develops drugs for the treatment of chemotherapeutic disease. It holds interest in the prevention and treatment of chemotherapeutic drug resistance and radiation therapyresistance. The firms offers products for the indication of cancer. The company was founded by Rudolf Fahrig in 2000 and is headquartered in Dresden, Germany. | Chief Tech/Sci/R&D Officer | 24.11.2009 |
| University of Bonn | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PROPANC BIOPHARMA, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
RESprotect GmbH
RESprotect GmbH Pharmaceuticals: OtherHealth Technology RESprotect GmbH develops drugs for the treatment of chemotherapeutic disease. It holds interest in the prevention and treatment of chemotherapeutic drug resistance and radiation therapyresistance. The firms offers products for the indication of cancer. The company was founded by Rudolf Fahrig in 2000 and is headquartered in Dresden, Germany. | Health Technology |
